UBS Group
HAO icon

UBS Group’s Haoxi Health Technology Ltd HAO Stock Holding History

UBS Group’s Portfolio HAO Stock Details HAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Hold
0
– -$468 – 11132
2026
Q1 		– Hold
0
– – – 9877
2025
Q4 		– Hold
0
– – – 9988
2025
Q3 		– Sell
-2
Closed -$5.9K – 11045
2025
Q2 		$5.9K Sell
2
-5
-71% -$16.9K ﹤0.01% 9128
2025
Q1 		$23.9K Buy
7
+2
+40% +$11.9K ﹤0.01% 8104
2024
Q4 		$49.2K Buy
5
+4
+400% +$45.7K ﹤0.01% 7309
2024
Q3 		$28.4K Buy
+1
New +$235K ﹤0.01% 7150
2024
Q2 		– Hold
0
– – – 6592
2024
Q1 		– Hold
0
– – – 8517

Other funds holding HAO

MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

UBS Group's HAO Position: Q2 2026 in Review

UBS Group held its Haoxi Health Technology Ltd (HAO) position steady in Q2 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #11132.

UBS Group first reported a position in HAO in Q3 2024 and has held it in 4 quarters since. The position peaked at $49.2K in Q4 2024. 3 funds tracked by Wall St. Rank hold HAO as of Q2 2026.

  • UBS Group held 0 shares of Haoxi Health Technology Ltd worth $0 as of Q2 2026.
  • UBS Group left its Haoxi Health Technology Ltd share count unchanged in Q2 2026.
  • Haoxi Health Technology Ltd made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #11132 holding.
  • UBS Group first reported a position in Haoxi Health Technology Ltd in Q3 2024 and has held it in 4 quarters since.
  • UBS Group's Haoxi Health Technology Ltd position peaked at $49.2K in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Haoxi Health Technology Ltd as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.